Evidence map›Paper›PMID 42465929›Full record

ArticlemedRxiv : the preprint server for health sciences2026

NEXIM: A Nash Equilibrium-Based Framework for Stable Explainable AI in Medical Applications.

Dipak P Upadhyaya, Deepak K Gupta, Katrina Prantzalos, Pedram Golnari, Vivikta Lyer, Cole Zweber, Subhashini Sivagnanam, Amitava Majumdar, Satya S Sahoo

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Dipak P UpadhyayaDepartment of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, USA.ORCID 0000-0001-9068-5450
Deepak K GuptaDepartment of Neurological Sciences, Larner College of Medicine, University of Vermont, Burlington, VT, USA.
Katrina PrantzalosDepartment of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Pedram GolnariDepartment of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Vivikta LyerDepartment of Neurological Sciences, Larner College of Medicine, University of Vermont, Burlington, VT, USA.
Cole ZweberDepartment of Neurological Sciences, Larner College of Medicine, University of Vermont, Burlington, VT, USA.
Subhashini SivagnanamSan Diego Supercomputer Center, University of California, San Diego, CA, USA.
Amitava MajumdarSan Diego Supercomputer Center, University of California, San Diego, CA, USA.
Satya S SahooDepartment of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, USA.

Funding

Clinical and Translational Science Collaborative of ClevelandUL1TR002548 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI MCCOMSEY, GRACE A · 2018 to 2022
$35.5M
Neuroscience Gateway to Enable Dissemination of Computational And Data Processing Tools And Software.U24EB029005 · NIBIB · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MAJUMDAR, AMITAVA · 2019 to 2023
$2.2M
CRCNS:NeuroBridge: Connecting Big Data for Reproducible Clinical NeuroscienceR01DA053028 · NIDA · OHIO STATE UNIVERSITY · PI AMBITE, JOSE LUIS, RAJASEKAR, ARCOT · 2020 to 2023
$1.7M
Clinical and Translational Science Collaborative of Northern Ohio, CTSA Postdoctoral T32 at Case Western Reserve UniversityT32TR004520 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI James Spilsbury · 2023 to 2026
$1.2M
NCATS NIH HHS T32 TR004520NCATS NIH HHS UL1 TR002548NIBIB NIH HHS U24 EB029005NIDA NIH HHS R01 DA053028
6 · The paper itself

Abstract

Reliable explanations are important for trustworthy medical applications of artificial intelligence (AI), but attribution-based explanations can vary across model randomization and small analytic changes. We present NEXIM (Nash Equilibrium-based Explainability and Interpretability Model), implemented here as an accuracy-constrained, equilibrium-inspired model-selection framework that jointly evaluates held-out prediction error, explanation stability, and cross-model connectivity. The implementation evaluated ten GradientBoostingRegressor models per prediction horizon, differing only by random seed (0-9), using a fixed 75/25 patient split. Kernel SHAP attribution vectors were compared using Spearman rank correlation, and graph connectivity summarized whether each model belonged to a dense explanation-similarity region. Candidate models within 0.02 Montreal Cognitive Assessment points of the best root mean squared error (RMSE) were ranked using a multiplicative Explanation Equilibrium Score. In longitudinal Parkinson's Progression Markers Initiative data, NEXIM selected the RMSE-optimal model at the one- and three-year horizons. At the two-year horizon, it selected Model 4 rather than the RMSE-only Model 8, increasing scaled stability from 0.8757 to 0.8847 and normalized graph connectivity from 0.889 to 1.000 while increasing RMSE by only 0.0014. The two models retained the same top-20 feature set but differed modestly in feature order, illustrating that NEXIM primarily acted as a reproducibility screen rather than identifying clinically contradictory explanations. Stability and consensus are treated as reproducibility criteria, not evidence of causal faithfulness, clinical usefulness, or improved patient outcomes. NEXIM may therefore serve as a governance checkpoint for model refresh and documentation, but external validation, stronger model-family baselines, and prospective clinical evaluation remain necessary.

Identifiers

PMID42465929
PMCPMC13370577

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.